Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers February 15, 2019
Pharmacy Choice - Pharmaceutical News - Bipartisan, bicameral legislation would counter most common delay tactics used by name-brand manufacturers to prevent lower-cost generic competition - February 15, 2019

Pharmacy News Article

 2/8/19 - Bipartisan, bicameral legislation would counter most common delay tactics used by name-brand manufacturers to prevent lower-cost generic competition

WASHINGTON, D.C. - U.S. Senator Tammy Baldwin helped reintroduce bipartisan legislation to combat anticompetitive practices used by some brand-name pharmaceutical and biologic companies to block entry of lower-cost generic drugs.

The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act would deter pharmaceutical companies from blocking cheaper generic alternatives from entering the marketplace.

"I've heard from countless Wisconsinites who can't afford the rising costs of the prescription medication they need. They want Washington to act and this bipartisan reform will take on the unfair practices of some brand-name pharmaceutical companies that drive up prescription drug costs," said Senator Baldwin. "Lower-cost generic drugs shouldn't be blocked from the marketplace by big drug companies. This bipartisan legislation will make more affordable prescription drug options available to consumers who should be able to get the medications they need at a price they can afford."

The Congressional Budget Office has estimated that the bill would result in a $3.9 billion net decrease in the federal deficit. Savings to consumers and private insurers likely would be far greater - many billions of dollars more.

The legislation, a version of which was introduced in the House earlier this year, is strongly supported by a coalition of groups including the AARP, American College of Physicians, FreedomWorks, Coalition for Affordable Prescription Drugs and many more. The full list of supporters is available here

The bill is led by Senators Patrick Leahy (D-VT), Chuck Grassley (R-IA), Amy Klobuchar (D-MN) and Mike Lee (R-UT). The bill is also cosponsored by Senators Richard Blumenthal (D-CT), Cory Booker (D-NJ), Sherrod Brown (D-OH), Susan Collins (R-ME), Tom Cotton (R-AR), Ted Cruz (R-TX), Steve Daines (R-MT), Dick Durbin (D-IL), Joni Ernst (R-IA), Dianne Feinstein (D-CA), Deb Fischer (R-NE), Maggie Hassan (D-NH), John Kennedy (R-LA), Angus King (I-ME), Bob Menendez (D-NJ), Lisa Murkowski (R-AK), Rand Paul (R-KY), Mike Rounds (R-SD), Tina Smith (D-MN), Debbie Stabenow (D-MI), Jon Tester (D-MT), Sheldon Whitehouse (D-RI) and Todd Young (R-IN).

More information about the CREATES Act is available here

Read this original document at:

Copyright (c) 2019 Federal Information & News Dispatch, Inc.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Feb 18: Management of Schizophrenia & Acute Agitation
Feb 19: Treatment of Atopic Dermatitis (Eczema) & Xerosis (Dry Skin)
Feb 20: Know Your Value, Know Your Worth: Provider Status in Pharmacy
Feb 21: Type II Diabetes: Case Studies and Management Options
Feb 22: Medical Marijuana: The Basic and Clinical Pharmacology, Not The Politics
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement